PREVALENCE OF SCAPULAR DYSKINESIS (NCT07123532) | Clinical Trial Compass
RecruitingNot Applicable
PREVALENCE OF SCAPULAR DYSKINESIS
Egypt121 participantsStarted 2025-08-01
Plain-language summary
Objective:
This study will aim to determine the prevalence of scapular dyskinesis (SD) among Egyptian physical therapy practitioners and will explore associated epidemiological factors, including age, sex, BMI, shoulder and neck symptoms, and scapular stabilizer muscle strength.
Design:
A cross-sectional observational study will be conducted, including 121 licensed Egyptian physical therapists aged 27 to 40 years. Participants will be divided into three age-based groups.
Methods:
Each participant will undergo a clinical examination for SD using the Scapular Dyskinesis Test (SDT) and the Lateral Scapular Slide Test (LSST). Pain intensity will be assessed using the Visual Analog Scale (VAS), and musculoskeletal symptoms will be recorded using the Nordic Musculoskeletal Questionnaire (NMQ). Shoulder range of motion and the strength of scapular stabilizer muscles (serratus anterior, middle, and lower trapezius) will also be evaluated. Statistical analysis will include Chi-square tests and one-way ANOVA at a significance level of p \< 0.05.
Who can participate
Age range
27 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Licensed physical therapy practitioners actively working in clinical settings (Soliño et al., 2024).
Age between 27 and 40 years (Jeong \& Kim, 2023).
Minimum of one year of clinical experience or exposure to physical activity (Jeong \& Kim, 2023).
No current shoulder pain or symptoms at the time of assessment (Soliño et al., 2024).
Willingness to participate and provide informed consent.
Exclusion Criteria:
Acute shoulder or neck injury within the last month (Jeong \& Kim, 2023).
History of upper body orthopedic surgery (Jeong \& Kim, 2023).
Known neurological or musculoskeletal disorders affecting shoulder mechanics (Burn et al., 2016).
Participation in overhead or collision sports with high scapular loading (Burn et al., 2016).
Inability to complete assessment procedures due to physical limitations (Soliño et al., 2024).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Prevalence of Scapular Dyskinesis
Timeframe: At baseline (single assessment session).